MedPath

Progesterone

Generic Name
Progesterone
Brand Names
Bijuva, Crinone, Endometrin, Prochieve, Prometrium
Drug Type
Small Molecule
Chemical Formula
C21H30O2
CAS Number
57-83-0
Unique Ingredient Identifier
4G7DS2Q64Y
Background

Progesterone is a hormone that occurs naturally in females, and is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss . Progesterone is used in various contraceptive preparations to prevent ovulation and fertilization , as well as in other formulations to promote and support pregnancy. Please see Medroxyprogesterone acetate, Megestrol acetate, Dydrogesterone and Hydroxyprogesterone entries for information on various other forms of progesterone.

Pharmaceutical progesterone is made from a plant source as a starting material and is chemically identical to progesterone of human ovarian origin . Progesterone is available in gelatinized capsule form, vaginal gel form, tablet form, vaginal insert form, and injection form, all used for various purposes .

Indication

Gelatinized capsules

The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea .

Vaginal gel

Progesterone gel (8%) is indicated as progesterone supplementation or replacement as part of an Assisted Reproductive Technology (“ART”) treatment for infertile women with progesterone deficiency. The lower concentration progesterone gel (4%) is used in the treatment of secondary amenorrhea, with the use of the 8% concentration if there is no therapeutic response to the 4% gel .

Vaginal insert

This form is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women .

Injection (intramuscular)

This drug is indicated in amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer .

Tablets, contraceptive

The tablet form of progesterone in contraceptive formulations is indicated for the prevention of pregnancy .

Associated Conditions
Abnormal Uterine Bleeding, Amenorrhea, Endometrial hyperplasia caused by conjugated estrogen, Moderate to Severe Vasomotor Symptoms, Pregnancy, Secondary Amenorrhea, Recurrent spontaneous preterm birth
Associated Therapies
Assisted Reproductive Technology therapy

Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles

Phase 4
Conditions
Infertility, Female
Infertility, Male
Embryo Transfer
Fertilization in Vitro
Drug Effect
Reproductive Techniques, Assisted
Progesterone
Dydrogesterone
Interventions
First Posted Date
2019-10-14
Last Posted Date
2019-10-14
Lead Sponsor
Memorial Sisli Hospital, Istanbul
Target Recruit Count
140
Registration Number
NCT04124913
Locations
🇹🇷

Memorial Şişli Hospital, Istanbul, Şişli, Turkey

Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.

Not Applicable
Completed
Conditions
Infertility
IVF
Preimplantation Diagnosis
Interventions
First Posted Date
2019-09-27
Last Posted Date
2023-05-15
Lead Sponsor
Institut Universitari Dexeus
Target Recruit Count
44
Registration Number
NCT04108039
Locations
🇪🇸

Institut Universitari Dexeus, Barcelona, Catalunya, Spain

Detection of Preterm Labour by Cervical Length

Early Phase 1
Conditions
Preterm Labour
Interventions
Other: digital vaginal exam
Device: transvaginal ultrasound
Device: abdominal ultrasound
Drug: Tocolytic Agents
Procedure: cervical cercalage
First Posted Date
2019-09-26
Last Posted Date
2020-01-14
Lead Sponsor
Assiut University
Target Recruit Count
966
Registration Number
NCT04104984

Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model

Phase 2
Completed
Conditions
Perinatal Depression
Post Partum Depression
Depression
Depression, Postpartum
Interventions
First Posted Date
2019-08-09
Last Posted Date
2023-08-25
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
23
Registration Number
NCT04051320
Locations
🇺🇸

University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States

Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer

Early Phase 1
Conditions
Endometrial Cancer Stage I
Interventions
Drug: PD-1 inhibitor combined progesterone
First Posted Date
2019-08-06
Last Posted Date
2019-08-06
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
60
Registration Number
NCT04046185

Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

Phase 4
Completed
Conditions
Assisted Reproduction
Interventions
Drug: combined oral contaraceptive pills
Drug: Urinaru gonadotropin
Procedure: Embryo transfer
Procedure: Ovum pick up
First Posted Date
2019-07-05
Last Posted Date
2019-07-05
Lead Sponsor
Cairo University
Target Recruit Count
160
Registration Number
NCT04008966
Locations
🇪🇬

Kasr Alainy medical school, Cairo, Egypt

Progesterone Versus Progesterone Plus Dydrogesterone in FET

Not Applicable
Completed
Conditions
Infertility
Interventions
First Posted Date
2019-06-26
Last Posted Date
2021-02-24
Lead Sponsor
Mỹ Đức Hospital
Target Recruit Count
1364
Registration Number
NCT03998761
Locations
🇻🇳

Mỹ Đức Hospital, Ho Chi Minh City, Tan Binh, Vietnam

Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia

Not Applicable
Completed
Conditions
Endometrial Hyperplasia Without Atypia
Interventions
Device: Levonorgestrel-Intrauterine System
First Posted Date
2019-06-20
Last Posted Date
2020-12-02
Lead Sponsor
Kocaeli University
Target Recruit Count
132
Registration Number
NCT03992937
Locations
🇹🇷

Kocaeli University, Kocaeli, Turkey

Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients

Phase 4
Terminated
Conditions
Miscarriage
Frozen Embryo Transfer
Natural Cycle
Hormone Replacement Therapy Cycle
Preimplantation Genetic Screening
Euploid Embryos
Interventions
First Posted Date
2019-06-06
Last Posted Date
2025-01-28
Lead Sponsor
CRG UZ Brussel
Target Recruit Count
362
Registration Number
NCT03976544
Locations
🇧🇪

Centre for Reproductive Medicine UZ Brussel, Brussels, Belgium

Luteal Support in Frozen-Thawed Embryo Transfer Cycles

Phase 4
Completed
Conditions
Luteal Support
Assisted Reproduction
Implantation; Placenta
Pregnancy Loss
Frozen Embryo
Luteal Phase Defect
Interventions
First Posted Date
2019-05-13
Last Posted Date
2022-01-11
Lead Sponsor
Centrum Clinic IVF Center
Target Recruit Count
151
Registration Number
NCT03948022
Locations
🇹🇷

Ufuk University School of Medicine, Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath